Alnylam Pharmaceuticals (ALNY) Stock Chart & Stock Price History $246.27 -2.89 (-1.16%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Alnylam Pharmaceuticals Stock Price Performance 5 Day Performance-1.89%1 Month Performance+0.34%3 Month Performance-16.78%6 Month Performance+3.55%Year-To-Date Performance+4.66%1 Year Performance+33.82% Receive ALNY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Alnylam Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address ALNY Stock Chart for Monday, January, 20, 2025 ALNY Chart by TradingView Alnylam Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization01/17/2025$249.16$246.27-1.16%$253.50$245.69556,461 shs$31.76 billion01/16/2025$251.01$249.16-0.74%$256.93$247.90683,877 shs$32.38 billion01/15/2025$240.51$251.01+4.37%$255.30$244.00870,422 shs$32.38 billion01/14/2025$258.27$240.51-6.88%$259.60$240.02783,774 shs$31.02 billion01/13/2025$237.98$258.27+8.53%$261.86$236.871.22 million shs$33.31 billion01/10/2025$240.55$237.98-1.07%$240.17$232.82705,218 shs$30.69 billion01/09/2025$240.55$240.55$240.65$234.11653,976 shs$31.03 billion01/08/2025$235.95$240.55+1.95%$240.65$234.11653,976 shs$31.03 billion01/07/2025$233.15$235.95+1.20%$239.23$232.98628,968 shs$30.43 billion01/06/2025$234.28$233.15-0.48%$237.49$231.00561,513 shs$30.07 billion Get the Latest News and Ratings for ALNY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Alnylam Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 01/03/2025$233.62$234.28+0.28%$235.52$232.35411,197 shs$30.22 billion01/02/2025$235.31$233.62-0.72%$239.99$232.25392,740 shs$30.13 billion01/01/2025$235.31$235.31$238.44$235.16370,079 shs$30.35 billion12/31/2024$236.01$235.31-0.30%$238.44$235.16370,079 shs$30.35 billion12/30/2024$237.97$236.01-0.82%$236.95$233.00382,342 shs$30.44 billion12/27/2024$242.50$237.97-1.87%$243.61$237.15342,907 shs$30.69 billion12/26/2024$243.25$242.50-0.31%$244.82$240.43358,560 shs$31.28 billion12/25/2024$243.25$243.25$243.90$236.70253,070 shs$31.37 billion12/24/2024$242.26$243.25+0.41%$243.90$236.70253,070 shs$31.37 billion12/23/2024$245.44$242.26-1.30%$244.64$237.12718,087 shs$31.25 billion12/20/2024$238.87$245.44+2.75%$247.21$235.931.65 million shs$31.66 billion12/19/2024$237.92$238.87+0.40%$242.87$233.41974,942 shs$30.81 billion Related Companies Gilead Sciences Stock Price Chart Vertex Pharmaceuticals Stock Price Chart Regeneron Pharmaceuticals Stock Price Chart Biogen Stock Price Chart United Therapeutics Stock Price Chart Neurocrine Biosciences Stock Price Chart Incyte Stock Price Chart BioMarin Pharmaceutical Stock Price Chart Exact Sciences Stock Price Chart Exelixis Stock Price Chart Receive ALNY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Alnylam Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ALNY) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementThe #1 Coin Poised to Soar Under Trump Pro-Crypto White House could make this the investment opportunity of...Crypto 101 Media | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alnylam Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alnylam Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
